Lion Point Capital »

Gh Research shares owned by Lion Point Capital

Quarter-by-quarter ownership of Gh Research (GHRS) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Gh Research

Tip: Access up to 7 years of quarterly data

All positions including Gh Research held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gh Research by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $130k 10k 12.70

More positions owned by Lion Point Capital

Milestone Pharmaceuticals (MIST)
Praxis Precision Medicines I Com New (PRAX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Fennec Pharmaceuticals (FENC)
Jasper Therapeutics Com New (JSPR)
Benitec Biopharma Com New (BNTC)
Royalty Pharma Shs Class A (RPRX)
Geron Corporation (GERN)
Syndax Pharmaceuticals (SNDX)
Ardelyx (ARDX)
Cue Biopharma (CUE)
Disc Medicine (IRON)
Sarepta Therapeutics (SRPT)
Biohaven (BHVN)
Humacyte (HUMA)

View all positions for Lion Point Capital

Top funds holding Gh Research

Lynx1 Capital Management
BVF
RA Capital Management
Rtw Investments
FMR
venBio Select Advisor
Cormorant Asset Management
Millennium Management
Leucadia National Corporation
Verition Fund Management
5AM Venture Management
BlackRock
Troluce Capital Advisors
UBS Group
CenterBook Partners

View all funds holding Gh Research